04 September 2019
Visiongain has launched a new pharma report Cervical Pillows Market Report: By Material (Foam Pillows, Fiber Filled Pillows, Memory Foam Pillows, Water Filled Pillows, Gas Filled Pillows, Gel Filled Pillows, Others), by Application (Cervical Spondylosis, Trauma Based Whiplash Recovery, Temporomandibular Disorders, Others), by Distribution Channel (Hospital, Retail, Online) and by Region.
Global cervical pillows Market is anticipated to grow on account of growing cases of vehicle accidents and sports injuries causing damage to neck and spinal cord. The global cervical pillows market is anticipated to grow at a lucrative CAGR of 5.3% and anticipated to reach USD 7.24 Billion by 2029.
It is anticipated that growing prevalence of spondylosis and growing cervical disorders is fueling the growth of cervical pillows market globally. Rising number of working professionals exhibiting sedentary lifestyles, and obesity enhances the risk for spondylosis. Furthermore, age is a main factor that increases spondylosis risk. Accelerating geriatric demographic proportion will drive cervical pillow demand.
Neck pain is currently one of the most prevalent ailments. Neck and spine, nerves, and muscles are coordinated. If neck pain persists for a substantial period, it can lead to head, shoulders, and arms pain. Furthermore, if neck pain stays untreated, it can become chronic. According to National Center for Biotechnology Information, Neck pain is one of the main musculoskeletal illnesses in adults, prevalence ranging from 16.7% to 75.1% across the globe. This disease has a complicated etiology, including a number of variables: ergonomic (strenuous physical activity, use of strength and vibration, insufficient posture, repetitive motion), individual (age, body mass index, genome, history of musculoskeletal pain), cognitive (smoking and physical activity level), and psychosocial (work satisfaction, stress, anxiety, and depression).
North America holds majority of market share followed by Europe and will continue to dominate in the future due to sedentary lifestyle of people coupled with growing healthcare expenditure in the region. According to United States Bone and Joint Initiative, In the U.S. alone, musculoskeletal circumstances rank first among illnesses using disability interventions; visits to offices of doctors; and impairments. Musculoskeletal circumstances are a cause of disability for half of all individuals reporting such impairments in performing daily living activities. Back and spine impairments are also the most common among musculoskeletal impairments, affecting more than 1 in 4 adults per year and accounting for 53.8 million visits to doctors in 2012. Back pain is also a significant cause of disability and work-limited incapacity. For any cause, back pain accounts for 1 out of 20 health care visits. Asia Pacific region is expected to experience the highest growth in terms of CAGR over the forecast period owing to growing geriatric population, changing lifestyle patterns, long working hours and poor sitting postures in region such as China, India and Japan.
Currently, key players are forming various strategies such as acquisitions, mergers, partnerships, collaborations and launching new products in order to strengthen their position in the global single-cell genomics market. Companies are also expanding their R&D, distribution, and management facilities to expand their business and to hold a competitive edge in the market.
For example, Malouf introduced aromatherapy scented pillows to improve sleep quality. Similarly, merger of Sleep Innovations, Inc. with Flexible Foam Products, Inc. in order to form Innocor, Inc. company and expand its product portfolio.
The comprehensive market report features companies such as Alex Orthopedic, Inc., Arc4life, Carpenter Co., CNH Pillow Inc., Coop Home Goods, Core Products International, Inc, Cr Sleep, Crown Medical Products, Inc., Custom craftwork, DC Labs, Djo Global, Hall Innovations, LLC, Innocor Inc., J-Pillow Ltd, Lohmann & Rauscher International GmbH & Co. KG, Malouf, Mediflow Inc, My Pillow, PharMeDoc, Snuggle Pedicure, Therapeutic Pillow International and Xtreme Comforts among other prominent players.
Also the research study offers market estimation and forecast for the period ranging 2019–2029 for global markets such as North America, Latin America, Western Europe, Eastern Europe, Asia Pacific and MEA along with regional sub-markets as U.S., Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, Nordic, Benelux, Russia, Poland, India, Japan, China, Australia, ASEAN, GCC, South Africa and North Africa.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 207 336 6100.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.
21 July 2021
Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.
20 July 2021
Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.
14 July 2021
Digital innovation in clinical trials and renewed focus on home production will ensure a high growth market for supply chain optimisation.